menu
    • menu

    Company profile for Aravive

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aravive Biologics, Inc., is an innovative pharmaceutical company dedicated to translating fundamental biological insights into new therapies that address major unmet clinical needs. Our approach is to target critical survival pathways both for hematologic malignancies as well as advanced solid tumors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AraviveUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    LyondellBasell Tower 1221 McKinney Street Suite 3200 Houston, Texas 77010
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aravive.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aravive, Inc. to Delist from The Nasdaq Stock Market
    Aravive, Inc. to Delist from The Nasdaq Stock Market

    17 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/17/2811132/30446/en/Aravive-Inc-to-Delist-from-The-Nasdaq-Stock-Market.html

    GLOBENEWSWIRE
    17 Jan 2024
    Share Share
    Aravive, weeks from liquidation, lays off 70% of its staff
    Aravive, weeks from liquidation, lays off 70% of its staff

    22 Aug 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/aravive-weeks-liquidation-lays-70-its-staff-it-seeks-savior

    Nick Paul Taylor FIERCE BIOTECH
    22 Aug 2023
    Share Share
    Phase 3 cancer flop blows hole in plans of cast-strapped Aravive
    Phase 3 cancer flop blows hole in plans of cast-strapped Aravive

    03 Aug 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/araviv-ederci-phase-3-cancer-flop-blows-hole-plans-cast-strapped-biotech

    Nick Paul Taylor FIERCE BIOTECH
    03 Aug 2023
    Share Share
    Aravive Announces Top-Line Results from Phase 3 AXLerate-OC Study of Batiraxcept
    Aravive Announces Top-Line Results from Phase 3 AXLerate-OC Study of Batiraxcept

    02 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/08/02/2717335/30446/en/Aravive-Announces-Top-Line-Results-from-Phase-3-AXLerate-OC-Study-of-Batiraxcept-in-Platinum-Resistant-Ovarian-Cancer.html

    GLOBENEWSWIRE
    02 Aug 2023
    Share Share
    Aravive to Present Updated Clinical Data from Batiraxcept Trials
    Aravive to Present Updated Clinical Data from Batiraxcept Trials

    28 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/28/2713027/30446/en/Aravive-to-Present-Updated-Clinical-Data-from-Batiraxcept-Trials-in-Renal-and-Pancreatic-Cancer-at-ESMO-Congress-2023.html

    GLOBENEWSWIRE
    28 Jul 2023
    Share Share
    Aravive to Participate in William Blair's Innovator Series
    Aravive to Participate in William Blair's Innovator Series

    14 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/14/2704921/30446/en/Aravive-to-Participate-in-William-Blair-s-Innovator-Series-Transitioning-Biotech-Breakthroughs-to-Commercial-Success-Being-Held-July-18-2023.html

    GLOBENEWSWIRE
    14 Jul 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search